Status:
COMPLETED
Coenzyme Q10 and Clomiphene Citrate (CC) for Ovulation Induction in Polycystic Ovary Syndrome
Lead Sponsor:
Mansoura University
Conditions:
Polycystic Ovary Syndrome
Eligibility:
FEMALE
Phase:
NA
Brief Summary
Objective of the study was to evaluate the effect of combination of oral Coenzyme Q10 (CoQ10), with clomiphene citrate (CC) for ovulation induction in CC-resistant polycystic ovary syndrome (PCOS).In ...
Detailed Description
No more details
Eligibility Criteria
Inclusion
- Diagnosis of PCOS based on the revised 2003 consensus on diagnostic criteria and long-term health risks related to PCOS (2003).
- All women were previously treated with 100 mg of CC daily for 5 days per cycle, for two to three cycles with persistent anovulation or ovulate with very thin endometrium \<5 mm at the time of hCG administration
Exclusion
- patients with hyperprolactinaemia,
- hypercorticism and
- thyroid dysfunction.
- patients receiving medications as cholesterol lowering drugs, as statins, beta-blockers, and tricyclic antidepressants
Key Trial Info
Start Date :
January 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2013
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT01910766
Start Date
January 1 2010
End Date
January 1 2013
Last Update
July 30 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mansoura University Hospitals
Al Mansurah, Dakahlia Governorate, Egypt, 35111